OssDsign Catalyst now available on the U.S. market
Uppsala, Sweden, 08:00 CET, 16 August 2021 – OssDsign today announces that OssDsign Catalyst has been launched and is now ready for sale in the U.S. This marks an important step in the company’s strategy of entering the highly scalable bone graft market with its innovative nanosynthetic bone graft that stimulates the formation of healthy bone tissue.Nearly 80 percent of all Americans experience low back pain at some point in their lives and more than 1.5 million will undergo spinal fusion surgery. Approximately 20 percent of these surgeries are unsuccessful due to the lack of proper fusion